Crown Castle (CCI)vsIDEXX Laboratories Inc (IDXX)
CCI
Crown Castle
$88.78
+3.39%
REAL ESTATE · Cap: $37.47B
IDXX
IDEXX Laboratories Inc
$560.80
+1.29%
HEALTHCARE · Cap: $44.08B
Smart Verdict
WallStSmart Research — data-driven comparison
IDEXX Laboratories Inc generates 2% more annual revenue ($4.30B vs $4.21B). CCI leads profitability with a 25.1% profit margin vs 24.6%. CCI appears more attractively valued with a PEG of 1.42. IDXX earns a higher WallStSmart Score of 61/100 (C+).
CCI
Buy51
out of 100
Grade: C-
IDXX
Buy61
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-13.3%
Fair Value
$75.96
Current Price
$88.78
$12.82 premium
Margin of Safety
-47.2%
Fair Value
$440.68
Current Price
$560.80
$120.12 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 47.7%
Conservative balance sheet, low leverage
Keeps 25 of every $100 in revenue as profit
Every $100 of equity generates 66 in profit
Keeps 25 of every $100 in revenue as profit
Strong operational efficiency at 29.8%
Areas to Watch
Premium valuation, high expectations priced in
Weak financial health signals
ROE of -206.7% — below average capital efficiency
Revenue declined 4.8%
Expensive relative to growth rate
Premium valuation, high expectations priced in
Trading at 27.8x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : CCI
The strongest argument for CCI centers on Operating Margin, Debt/Equity, Profit Margin. Profitability is solid with margins at 25.1% and operating margin at 47.7%. PEG of 1.42 suggests the stock is reasonably priced for its growth.
Bull Case : IDXX
The strongest argument for IDXX centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 24.6% and operating margin at 29.8%. Revenue growth of 14.3% demonstrates continued momentum.
Bear Case : CCI
The primary concerns for CCI are P/E Ratio, Piotroski F-Score, Return on Equity.
Bear Case : IDXX
The primary concerns for IDXX are PEG Ratio, P/E Ratio, Price/Book. A P/E of 42.4x leaves little room for execution misses.
Key Dynamics to Monitor
CCI profiles as a declining stock while IDXX is a mature play — different risk/reward profiles.
IDXX carries more volatility with a beta of 1.72 — expect wider price swings.
IDXX is growing revenue faster at 14.3% — sustainability is the question.
CCI generates stronger free cash flow (452M), providing more financial flexibility.
Bottom Line
IDXX scores higher overall (61/100 vs 51/100), backed by strong 24.6% margins and 14.3% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Crown Castle
REAL ESTATE · REIT - SPECIALTY · USA
Crown Castle is a real estate investment trust and provider of shared communications infrastructure in the United States. Its network includes over 40,000 cell towers and nearly 80,000 route miles of fiber supporting small cells and fiber solutions. Headquartered in Houston, Texas, the company has 100 offices nationwide.
Visit Website →IDEXX Laboratories Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.
Compare with Other REIT - SPECIALTY Stocks
Want to dig deeper into these stocks?